一、根据《中华人民共和国药品管理法》规定,为掌握药品生产、流通、使用过程中的质量动态,及时查处假药、劣药,保障人民用药安全,特制定本报告制度.二、报告内容:1.按“药品管理法”规定.有下列情形之一的为假药:(一)药品所含成份的名称与国家药品标准或省、自治区、直辖市药品标准规定不符合的. I. According to the provisions of the “Drug Administration Law of the People’s Republic of China”, this report system has been specially formulated in order to grasp the quality and dynamics during the process of drug production, distribution and use, and timely investigate and deal with counterfeit medicines, substandard medicines and people’s medicines. : 1. According to the “Drug Administration Law.” There are one of the following cases of counterfeit drugs: (a) the name of the ingredients contained in the drug and the national drug standards or provinces, autonomous regions and municipalities drug standards does not meet the requirements.